查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1159171

血小板生成素受體的全球市場(2022年～2028年)

Thrombopoietin Receptor Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

全球血小板生成素受體的市場規模在預測期間內預計將以大幅年複合成長率增長。FDA 對公司開發的藥物的批准增加正在推動市場的增長。

本報告提供全球血小板生成素受體市場相關調查分析，提供市場概要，競爭情形，市場分析，企業簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • Novartis International AG
  • Amgen Inc.
  • GlaxoSmithKline plc
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Ltd.
  • 主要策略分析
  • COVID-19對主要企業帶來的影響

第4章 市場區隔

  • 全球血小板生成素受體市場:各類型
    • 艾曲波帕乙醇胺
    • GSK-2285921
    • 羅米司亭
    • STST-4
    • 其他
  • 全球血小板生成素受體市場:各終端用戶
    • 診所
    • 醫院
    • 其他

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 全球其他地區

第6章 企業簡介

  • Intas Pharmaceuticals Ltd.
  • Rigel Pharmaceuticals, Inc.
  • Shionogi & Co., Ltd.
  • STATegics Inc.
  • AkaRx Inc
  • 3SBio Inc
Product Code: OMR2025870

Global Thrombopoietin Receptor Market Size, Share and Trends Analysis Report by Type (Eltrombopag Olamine, GSK-2285921, Romiplostim, STST-4, Others), by Application (Clinic, Hospital, Others) Forecast Period (2022-2028)

The global thrombopoietin receptor market is expected to rise at a substantial CAGR during the forecast period. The factors that are significantly contributing to the growth of the market include FDA approvals to the drugs developed by the companies and new launches by the market players operating in the thrombopoietin receptor market. For instance, in June 2019, Dova Pharmaceuticals, Inc. announced the approval of a supplemental New Drug Application (sNDA) that expands the use of DOPTELET (avatrombopag) by the US Food and Drug Administration (FDA). Moreover, in Oct 2019, Amgen announced that the U.S. Food and Drug Administration (FDA) approved Amgen's Supplemental Biologics License Application (sBLA) for Nplate® (romiplostim). The drug is used to treat adults with immune thrombocytopenia (ITP).

The global thrombopoietin receptor market is segmented based on type and application. Based on type, the market is segmented into Eltrombopag Olamine, GSK-2285921, Romiplostim, STST-4, Others. Based on application the market is segmented into Clinic, Hospital, Others. For instance, Promacta is a prescription pharmaceutical used to treat low blood platelet counts caused by persistent immune thrombocytopenia (ITP) in adults and children aged 1 year and older when previous ITP medications or spleen removal surgery have failed.

The global thrombopoietin receptor market is further segmented based on geography Including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East and Africa, and Latin America).

The major companies serving the Global Thrombopoietin Receptor market include Novartis International AG, Amgen Inc., GlaxoSmithKline plc, 3SBio, Inc., AkaRx, Inc., and others. The market players are contributing significantly to the growth of the market by the adoption of various strategies, including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the Global Thrombopoietin Receptor market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Thrombopoietin Receptor Market Research and Analysis by Type
  • Global Thrombopoietin Receptor Market Research and Analysis by Application

The Report Covers:

  • Comprehensive Research Methodology of the Global Thrombopoietin Receptor Market.
  • This report additionally includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Thrombopoietin Receptor Market.
  • Insights about market determinants that are stimulating the Global Thrombopoietin Receptor Market.
  • The regional distribution of forecasted revenues with detailed and extensive market segments.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on The Global Thrombopoietin Receptor Market
  • Recovery Scenario of Global Thrombopoietin Receptor Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Novartis International AG
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Amgen Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GlaxoSmithKline plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. Swot Analysis
    • 3.3.4. Recent Developments
  • 3.4. AstraZeneca PLC
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments

3.5. Takeda Pharmaceutical Company Ltd.

    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Thrombopoietin Receptor Market by Type
    • 4.1.1. Eltrombopag Olamine
    • 4.1.2. GSK-2285921
    • 4.1.3. Romiplostim
    • 4.1.4. STST-4
    • 4.1.5. Others
  • 4.2. Global Thrombopoietin Receptor Market by END-USER
    • 4.2.1. Clinic
    • 4.2.2. Hospital
    • 4.2.5. Others

5. Regional Analysis

  • 5.1. North America

5.1.1 United States

5.1.2 Canada

5.2. Europe

    • 5.2.1.UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 5.5. Intas Pharmaceuticals Ltd.
  • 5.6. Rigel Pharmaceuticals, Inc.
  • 5.7. Shionogi & Co., Ltd.
  • 5.8. STATegics Inc.
  • 5.9. AkaRx Inc
  • 5.10. 3SBio Inc

LIST OF TABLES

  • 1. GLOBAL THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL ELTROMBOPAG OLAMINE THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL GSK-2285921 THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL ROMIPLOSTIM THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL STST-4 THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL OTHER THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
  • 8. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 9. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 10. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 11. GLOBAL THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028($ MILLION)
  • 12. NORTH AMERICAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 15. EUROPEAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. EUROPEAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028($ MILLION)
  • 17. EUROPEAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 20. ASIA-PACIFIC THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL THROMBOPOIETIN RECEPTOR MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL THROMBOPOIETIN RECEPTOR MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL THROMBOPOIETIN RECEPTOR MARKET, 2021-2028 (%)
  • 4. GLOBAL THROMBOPOIETIN RECEPTOR MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL ELTROMBOPAG OLAMINE THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL GSK-2285921 THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL ROMIPLOSTIM THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL STST-4 THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL OTHER THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL THROMBOPOIETIN RECEPTOR MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 11. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN CLINIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN HOSPITAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN OTHER END-USER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. US THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. CANADA THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. UK THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. FRANCE THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. GERMANY THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. ITALY THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. SPAIN THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF EUROPE THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. INDIA THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. CHINA THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. JAPAN THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SOUTH KOREA THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)